Smoking cessation in patients with mental disorders

2013 ◽  
pp. 194-207
Author(s):  
Fabio Lugoboni
Keyword(s):  
Smoking Cessation ◽  
Mental Disorders

Smoking cessation for individuals living with mental disorders in Brazil: Increasing providers' commitment and impact

2021 ◽  
Author(s):  
João M. Castaldelli-Maia ◽  
Anderson S.M. Silva ◽  
Priscila D. Gonçalves ◽  
Mariana V. Sanches ◽  
Dângela L.S. Lassi ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Mental Disorders

Is it Feasible and Effective to Help Patients with Severe Mental Disorders to Quit Smoking?

2017 ◽  
Vol 41 (S1) ◽  
pp. S32-S33
Author(s):  
J. Bobes
Keyword(s):  
Smoking Cessation ◽  
Mental Disorders ◽  
Real World ◽  
Suicide Attempts ◽  
Severe Mental Disorders ◽  
Open Label ◽  
Skin Reactions ◽  
Term Efficacy ◽  
Quit Smoking ◽  
Elevated Liver Enzymes

Despite the proven association between smoking and high rates of medical morbidity and reduced life expectancy in people with severe mental disorders (SMD), their smoking rates do not decline as they do in the general population. We carried out a non-randomized, open-label, prospective, 9-month follow-up multicentre trial to investigate the clinical efficacy, safety and tolerability of a smoking cessation programme designed for the treatment of patients with SMD in the community under real-world clinical conditions. A total of 82 patients were enrolled. Short-term efficacy: The 12-week 7-day smoking cessation (self-reported cigarettes per day =0 and breath CO levels ≤9 ppm) prevalence was 49.3%, with no statistically significant differences between medications (transdermal nicotine patches 50.0% vs. varenicline 48.6%, chi-square =0.015, P = 1.000). Long-term efficacy: At weeks, 24 and 36, 41.3 and 37.3% of patients were abstinent, with no statistically significant differences between treatments. Safety and tolerability: No patients made suicide attempts or required hospitalization. There was no worsening of the scores on the psychometric scales. In both groups, patients significantly increased weight, without significant changes in vital signs or laboratory results, with the exception of significant decreases in ALP y LDL-cholesterol levels in the varenicline group. Patients under varenicline more frequently presented nausea/vomiting (P < 0.0005), patients under TNP experienced skin reactions more frequently (P = 0.002). Three patients under varenicline had elevated liver enzymes. In conclusion, we have demonstrated that in real-world clinical settings it is feasible and safe to help patients with stabilized severe mental disorders to quit smoking.Disclosure of interestThis work was partly supported by the Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (FIS PI10/01758) and Fondos Europeos de Desarrollo Regional (FEDER). The Health Services of the Principado de Asturias, Spain, donated part of the medication used in this study.

Smoking cessation improves clinical outcome in severe mental disorders and is modulated by genetic variability at CHRNA5 gene

2020 ◽  
Vol 222 ◽  
pp. 516-519
Author(s):  
A.G. Segura ◽  
M. Mitjans ◽  
M. Fatjó-Vilas ◽  
M.P. Garcia-Portilla ◽  
L. Garcia-Alvarez ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Mental Disorders ◽  
Genetic Variability ◽  
Clinical Outcome ◽  
Severe Mental Disorders

scholarly journals Smoking cessation in pregnant women with mental disorders: a cohort and nested qualitative study

2012 ◽  
Vol 120 (3) ◽  
pp. 362-370 ◽  
Author(s):  
LM Howard ◽  
D Bekele ◽  
M Rowe ◽  
J Demilew ◽  
S Bewley ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Mental Disorders ◽  
Qualitative Study ◽  
Pregnant Women

scholarly journals 828 – Smoking cessation in pregnant women with mental disorders: a cohort and nested qualitative study

2013 ◽  
Vol 28 ◽  
pp. 1 ◽  
Author(s):  
L. Howard ◽  
M. Rowe ◽  
S. Bewley ◽  
T. Marteau ◽  
J. Demilew
Keyword(s):  
Smoking Cessation ◽  
Mental Disorders ◽  
Qualitative Study ◽  
Pregnant Women

scholarly journals Characteristics of people with mental disorders differ between currently smoking and ceased smoking

2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
R Dahal ◽  
A Bharrarai ◽  
K Adhikari
Keyword(s):  
Smoking Cessation ◽  
Young People ◽  
Mental Disorders ◽  
Smoking Status ◽  
Composite International Diagnostic Interview ◽  
Canadian Community Health Survey ◽  
Self Report ◽  
World Health ◽  
Multivariable Logistic Regression Analysis ◽  
Quit Smoking

Abstract Introduction Although the prevalence of smoking is higher among people with mental disorders compared to those without mental disorders, people with mental disorders are less successful for smoking cessation. This study examined the variation in characteristics of people with mental disorders across those who are current smokers and former smokers. Methodology This study used the Public Used Microdata File of the Canadian Community Health Survey 2012. (n = 25,113). People with any mental health disorder in the last 12 months were identified using the World Health Organization Composite International Diagnostic Interview instrument. Smoking status was classified based on self-report responses as: current, former, and never smoking. Multivariable logistic regression analysis was used to examine the association between the characteristics of people with mental disorders and smoking cessation (vs continuation). Results Overall, the prevalence of current smoking, former smoking, and nonsmoker were 37.5%, 33.6%, and 28.8% respectively. Immigrants compared to Canadian-born (OR = 0.6, 95% CI = 0.3, 0.8) and those who were single (either widowed or divorced or separated or single) compared to married or living with a partner (OR = 0.4, 95% CI = 0.1, 0.6) were less likely to quit smoking. Similarly, less educated and young people were also less likely to quit smoking. Conclusions Young people, living alone, less educated, and immigrants are less successful to quit smoking. Findings indicate the social disparity in smoking cessation among people with mental disorders. This may have been related to the barriers in accessing smoking cessation support among this group. Key messages Findings underscore the disparity in smoking cessation among people with mental disorder. Implementation of tailored, personalized smoking cessation support may be helpful to address the challenges.

P.6.d.014 Psychopathological tolerability of varenicline and nicotine patches for smoking cessation in severe mental disorders

2014 ◽  
Vol 24 ◽  
pp. S694
Author(s):  
L. González-Blanco ◽  
M.P. García-Portilla ◽  
L. García-Álvarez ◽  
P.A. Sáiz ◽  
C. Iglesias ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Mental Disorders ◽  
Severe Mental Disorders ◽  
Nicotine Patches

Smoking Cessation Treatment for Patients With Mental Disorders Using CBT and Combined Pharmacotherapy

2017 ◽  
Vol 13 (4) ◽  
pp. 238-246 ◽  
Author(s):  
Aline Rodrigues Loreto ◽  
Carlos Felipe Cavalcanti Carvalho ◽  
Fernanda Piotto Frallonardo ◽  
Flavia Ismael ◽  
Arthur Guerra de Andrade ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Mental Disorders ◽  
Smoking Cessation Treatment ◽  
Cessation Treatment
Sign in / Sign up

Export Citation Format

Share Document